Similarly, Ren et al. identified JAK1 frameshift mutations mainly in gynecological cancers, primarily in endometrial and cervical cancer, when sequencing more than 3,000 tumors from various human tissues [10]. This evidence concerns the gene JAK1 and cervical carcinoma.